The Conversation (0)
Nephros provided an update to shareholders of their “activities and guidance” during the third quarter of 2017.
Nephros (OTCQB:NEPH) provided an update to shareholders of their “activities and guidance” during the third quarter of 2017.
As quoted in the press release:
General Corporate Update
HydraGuardand EndoPurUltrafilters
The Company has begun selling all versions of the EndoPur and HydraGuard to dialysis clinics and hospital facilities, respectively.
Commercial and Industrial Filtration Products
The Company expects to launch its 9,000 gallon lead-removal filter before the end of 2017. The dual stage filter will absorb soluble lead and retain particulate lead to provide a comprehensive solution for water that exceeds a lead concentration of 150 parts per million.
OLpūr H2H Hemodiafiltration Module
Vanderbilt University continues to treat patients with the Nephros OLpūr® H2H Hemodiafiltration Module. The Company has made additional progress in the development of the second generation hemodiafiltration module and expects to increase these activities as the Company achieves positive cash flow.
Click here to read the full press release.
Source: www.marketwired.com
